Aya El Helali is a Clinical Assistant Professor at The University of Hong Kong’s School of Clinical Medicine. Professor Helali recently joined the Department of Clinical Oncology at HKU, and co-chairs the HKU-HKSH Molecular Tumor Board. She earned her MB BCh BAO with first-class honors from the National University of Ireland Galway, and a PhD from Queen’s University Belfast where she was awarded the Sir Allen McClay Clinical Research Fellowship. Her work focuses on biomarker development, adaptive immunity, and the molecular characteristics of ovarian cancer, influencing the use of anti-angiogenics.